Aardvark Therapeutics (AARD) Misses Q4 EPS by 81c
Tweet
Share
E-mailGet Alerts AARD Hot Sheet
Join SI Premium – FREE
Aardvark Therapeutics (NASDAQ: AARD) reported Q4 EPS of ($0.81).
For earnings history and earnings-related data on Aardvark Therapeutics (AARD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- Raymond James Resumes Commerce Bancshares (CBSH) at Market Perform
- PagerDuty, Inc. (PD) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
